Pricing database updated August 4, 2026Methodology v1.0How we score →
Compare Providers
Home / Provider Reviews / Shed Review
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
Written by Kim Callender, NP, FNP-BC·Published July 12, 2026·Last reviewed August 4, 2026·Prices verified August 4, 2026·Methodology v1.0
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Shed review (2026): pricing, programs, pros & limitations

Verdict

The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan. Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything. This review reflects figures marked reported — pending verification as of August 4, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.

What does this provider actually offer?

Shed snapshot — verification status per field, July 12, 2026
FieldDetailStatus
Starting price$149/mo (sema microdose)Reported — pending verification
Renewal price$175–$474 depending on productReported — pending verification
Highest-dose priceRISES at higher doses on injectablesReported — pending verification
Membership fee$125/mo for brand-nameReported — pending verification
LabsPending researchReported — pending verification
ShippingIncludedReported — pending verification
Commitment2-month minimumReported — pending verification
PharmacyNot independently verifiedReported — pending verification
ClinicianClinical supportReported — pending verification
States servedPending researchReported — pending verification
Shed pricing across doses, July 12, 2026
$0$40$80$121$161Starting dose$149Every dose (flat)$149

Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.

What does it actually cost at a maintenance dose?

The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan.

Limitation: Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.

Who prescribes it, and what does the clinical review involve?

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Clinical support. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Which pharmacy fills it, and where does the medication come from?

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For Shed: Not independently verified.

Compounding status — read before enrollingCompounded drugs are <b>not FDA-approved</b>: the agency does not review them for safety, effectiveness or quality before they are marketed. Federal law also bars compounding drugs that are <b>essentially a copy</b> of a commercially available approved product — a bar that is lifted only while the drug is on the FDA shortage list. Both shortages are over. The FDA declared the tirzepatide shortage resolved on October 2, 2024 and the semaglutide shortage resolved on February 21, 2025, and enforcement discretion ended for all compounders between February 18 and May 22, 2025. On April 30, 2026 the FDA went further, proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list on a finding of no clinical need. Routine compounding of these molecules is therefore no longer lawful on the basis that made the market — a fact most comparison sites still describe as "permanent legitimacy." It is not.

Where does it hold up, and where does it fall short?

Advantages

  • Shed: The widest range of formats in the category: injections, sublingual drops, lozenges and or…
  • Pricing structure is disclosed clearly enough to evaluate
  • Clinician oversight is stated

Limitations

  • Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.
  • Pharmacy partner not independently verified by us yet

What did we verify, and what could we not?

Every material claim on this page traces to a source, a capture date and a verification status.

Evidence ledger — claim, source, date checked, status
ClaimSourceCheckedStatus
Starting priceProvider plan documentationJuly 12, 2026Reported — pending verification
Pharmacy partnerProvider disclosureJuly 12, 2026Reported — pending verification
Clinician / medical leadProvider disclosureJuly 12, 2026Reported — pending verification
Shipping termsProvider terms pageJuly 12, 2026Reported — pending verification
State availabilityProvider disclosureJuly 12, 2026Evaluation in progress

What else should you compare it against?

Compare Shed against NexLife · Found · Oak Longevity. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

What did the provider say when we asked?

Shed may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

Frequently asked questions

Is Shed legitimate?

Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.

How much does Shed cost?

$149/mo (sema microdose) to start (reported — pending verification). See the pricing section for renewal and highest-dose figures.

Does Shed require a prescription?

Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.

Sources

  1. Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
  2. CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
  3. U.S. Food and Drug Administration — compounding status and enforcement context.
  4. Our published scoring methodology, version 1.0.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.